

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.92974203 |
| 2 | negative T cell selection (GO:0043383) | 7.76235427 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.21073877 |
| 4 | positive T cell selection (GO:0043368) | 6.99935378 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.95326349 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.90608716 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.60143210 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.60143210 |
| 9 | T cell selection (GO:0045058) | 6.44599004 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.32016383 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.32016383 |
| 12 | thymic T cell selection (GO:0045061) | 6.30552370 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 6.25764436 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.21419372 |
| 15 | interferon-gamma production (GO:0032609) | 5.84632291 |
| 16 | response to interleukin-15 (GO:0070672) | 5.81627932 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.75689861 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.64982896 |
| 19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.48902953 |
| 20 | regulation of T cell tolerance induction (GO:0002664) | 5.41491376 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 5.38659646 |
| 22 | T cell receptor signaling pathway (GO:0050852) | 5.06657008 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.86154110 |
| 24 | T cell costimulation (GO:0031295) | 4.78028929 |
| 25 | tolerance induction (GO:0002507) | 4.77033005 |
| 26 | lymphocyte costimulation (GO:0031294) | 4.70228260 |
| 27 | T cell migration (GO:0072678) | 4.65261636 |
| 28 | leukocyte aggregation (GO:0070486) | 4.56968059 |
| 29 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.56145704 |
| 30 | positive regulation of tolerance induction (GO:0002645) | 4.42690101 |
| 31 | activated T cell proliferation (GO:0050798) | 4.37367099 |
| 32 | positive regulation of interleukin-2 production (GO:0032743) | 4.21076349 |
| 33 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.12655107 |
| 34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.12086165 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.05455332 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.04252465 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.94054668 |
| 38 | regulation of regulatory T cell differentiation (GO:0045589) | 3.89203597 |
| 39 | V(D)J recombination (GO:0033151) | 3.86749969 |
| 40 | regulation of tolerance induction (GO:0002643) | 3.86662451 |
| 41 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.81334941 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.67020019 |
| 43 | positive regulation of isotype switching (GO:0045830) | 3.63923027 |
| 44 | alpha-beta T cell activation (GO:0046631) | 3.60606648 |
| 45 | T cell differentiation (GO:0030217) | 3.59980146 |
| 46 | regulation of B cell differentiation (GO:0045577) | 3.59522068 |
| 47 | alpha-beta T cell differentiation (GO:0046632) | 3.55756964 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55459085 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55459085 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.55459085 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55459085 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.55459085 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55459085 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.54285748 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.47524417 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43310858 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42951375 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42447874 |
| 59 | regulation of response to interferon-gamma (GO:0060330) | 3.41400902 |
| 60 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.39443366 |
| 61 | regulation of isotype switching (GO:0045191) | 3.38720414 |
| 62 | cellular extravasation (GO:0045123) | 3.38202981 |
| 63 | detection of other organism (GO:0098543) | 3.37605736 |
| 64 | detection of bacterium (GO:0016045) | 3.35668359 |
| 65 | T cell homeostasis (GO:0043029) | 3.34106804 |
| 66 | endothelial tube morphogenesis (GO:0061154) | 3.32839293 |
| 67 | morphogenesis of an endothelium (GO:0003159) | 3.32839293 |
| 68 | leukocyte cell-cell adhesion (GO:0007159) | 3.32643202 |
| 69 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.31387333 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.26632504 |
| 71 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.26632504 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.26418184 |
| 73 | response to type I interferon (GO:0034340) | 3.26015036 |
| 74 | cellular response to type I interferon (GO:0071357) | 3.25410866 |
| 75 | type I interferon signaling pathway (GO:0060337) | 3.25410866 |
| 76 | lymphocyte homeostasis (GO:0002260) | 3.19362444 |
| 77 | regulation of interleukin-2 production (GO:0032663) | 3.17481854 |
| 78 | B cell proliferation (GO:0042100) | 3.14086185 |
| 79 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12417015 |
| 80 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.12417015 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.09783833 |
| 82 | T cell activation (GO:0042110) | 3.07845647 |
| 83 | histone H3-K36 demethylation (GO:0070544) | 3.07371348 |
| 84 | positive regulation of DNA recombination (GO:0045911) | 3.07120619 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06828686 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05006047 |
| 87 | B cell homeostasis (GO:0001782) | 3.03719702 |
| 88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.03664053 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.03527338 |
| 90 | mast cell activation (GO:0045576) | 3.02870805 |
| 91 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.02788099 |
| 92 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02032117 |
| 93 | Peyers patch development (GO:0048541) | 3.02032117 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 3.00521950 |
| 95 | positive regulation of immunoglobulin production (GO:0002639) | 2.99685483 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 2.99429343 |
| 97 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.98688718 |
| 98 | regulation of granulocyte differentiation (GO:0030852) | 2.98491855 |
| 99 | natural killer cell activation (GO:0030101) | 2.97632516 |
| 100 | heterotypic cell-cell adhesion (GO:0034113) | 2.97480276 |
| 101 | positive regulation of humoral immune response (GO:0002922) | 2.97202876 |
| 102 | T cell proliferation (GO:0042098) | 2.95808451 |
| 103 | germinal center formation (GO:0002467) | 2.94351312 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.94319175 |
| 105 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.94319175 |
| 106 | regulation of defense response to virus by virus (GO:0050690) | 2.93315063 |
| 107 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.92438504 |
| 108 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.92202480 |
| 109 | regulation of immunoglobulin production (GO:0002637) | 2.90882126 |
| 110 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.89792201 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.89478980 |
| 112 | regulation of alpha-beta T cell activation (GO:0046634) | 2.89473930 |
| 113 | negative regulation of interleukin-12 production (GO:0032695) | 2.89079761 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86579889 |
| 115 | positive regulation of T cell activation (GO:0050870) | 2.85500746 |
| 116 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.85216667 |
| 117 | natural killer cell differentiation (GO:0001779) | 2.82055133 |
| 118 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80968530 |
| 119 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80968530 |
| 120 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.80956177 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.80741072 |
| 122 | hepatocyte apoptotic process (GO:0097284) | 2.80203746 |
| 123 | regulation of necroptotic process (GO:0060544) | 2.79043949 |
| 124 | positive regulation of histone deacetylation (GO:0031065) | 2.78994871 |
| 125 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.78486084 |
| 126 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77080347 |
| 127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76517796 |
| 128 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.74724865 |
| 129 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.74023730 |
| 130 | lymph node development (GO:0048535) | 2.73549520 |
| 131 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73501819 |
| 132 | regulation of B cell mediated immunity (GO:0002712) | 2.72826754 |
| 133 | lymphocyte differentiation (GO:0030098) | 2.72781388 |
| 134 | T-helper cell differentiation (GO:0042093) | 2.72163753 |
| 135 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.72163753 |
| 136 | regulation of B cell proliferation (GO:0030888) | 2.71523123 |
| 137 | positive regulation of B cell proliferation (GO:0030890) | 2.70884102 |
| 138 | establishment of endothelial barrier (GO:0061028) | 2.70857887 |
| 139 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.70556494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.08111234 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.41257918 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.08898367 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96694518 |
| 5 | * MYC_22102868_ChIP-Seq_BL_Human | 3.80935979 |
| 6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.73790167 |
| 7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.62237883 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.27924184 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.27220532 |
| 10 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22266244 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.19386309 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17684588 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.94163964 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91666035 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87996775 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.73610050 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.73136965 |
| 18 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61560478 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51473254 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39691456 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25616500 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.24284006 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06100647 |
| 24 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05840410 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.03827363 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99875495 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.99872456 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94791482 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90791663 |
| 30 | * MAF_26560356_Chip-Seq_TH2_Human | 1.89378097 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86750329 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84656960 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83510719 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81185191 |
| 35 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.80743286 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79808406 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78514442 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74715551 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74120294 |
| 40 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70111766 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68107670 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.67222161 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64486828 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64139423 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63441400 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61779485 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61022194 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55283891 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.53099346 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46136326 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44295091 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43413546 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42967410 |
| 54 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.42885686 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42305337 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36597981 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33537045 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25573276 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24053900 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22120928 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18677275 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15996134 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15952175 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11715551 |
| 65 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10865474 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08913737 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03608770 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03202922 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02474539 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01137115 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99716548 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99215889 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96657073 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96612898 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96036658 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95155633 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94602172 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92017164 |
| 79 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91217317 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91047106 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89118006 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88938976 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88885662 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88845781 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88197889 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87095823 |
| 87 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86881608 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85432964 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84128515 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83883469 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83139161 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82780687 |
| 93 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80238957 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78734380 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77240924 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75079225 |
| 97 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.75056856 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74899885 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74139267 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74054086 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73092015 |
| 102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.72644544 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.71793287 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70867594 |
| 105 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69899575 |
| 106 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.68438430 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.68222115 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68051803 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65201394 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64756741 |
| 111 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63362762 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63266949 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.62965769 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62898927 |
| 115 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.62455837 |
| 116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.60961288 |
| 117 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60737686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 4.82417889 |
| 2 | MP0005671_abnormal_response_to | 3.86502645 |
| 3 | MP0000685_abnormal_immune_system | 3.37688115 |
| 4 | MP0001800_abnormal_humoral_immune | 3.26523417 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.08006378 |
| 6 | MP0002166_altered_tumor_susceptibility | 3.06662734 |
| 7 | MP0005387_immune_system_phenotype | 3.05600201 |
| 8 | MP0001790_abnormal_immune_system | 3.05600201 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.80593712 |
| 10 | * MP0002398_abnormal_bone_marrow | 2.70679808 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.66154509 |
| 12 | * MP0001819_abnormal_immune_cell | 2.60734912 |
| 13 | * MP0000703_abnormal_thymus_morphology | 2.58351016 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.57763093 |
| 15 | MP0002723_abnormal_immune_serum | 2.56658563 |
| 16 | MP0001873_stomach_inflammation | 2.55535952 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.52779681 |
| 18 | * MP0000716_abnormal_immune_system | 2.33629663 |
| 19 | MP0002006_tumorigenesis | 2.33190450 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.24469578 |
| 21 | MP0003303_peritoneal_inflammation | 2.20794923 |
| 22 | MP0002405_respiratory_system_inflammati | 2.20465716 |
| 23 | * MP0002722_abnormal_immune_system | 2.19356875 |
| 24 | * MP0000689_abnormal_spleen_morphology | 2.16190638 |
| 25 | MP0002933_joint_inflammation | 2.15754966 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.12151816 |
| 27 | MP0003724_increased_susceptibility_to | 2.07630504 |
| 28 | MP0009785_altered_susceptibility_to | 2.05934982 |
| 29 | MP0004947_skin_inflammation | 2.03498896 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.94466194 |
| 31 | * MP0002429_abnormal_blood_cell | 1.92930439 |
| 32 | * MP0009333_abnormal_splenocyte_physiolog | 1.91852689 |
| 33 | MP0005025_abnormal_response_to | 1.91573543 |
| 34 | MP0003436_decreased_susceptibility_to | 1.85626876 |
| 35 | MP0006082_CNS_inflammation | 1.77601508 |
| 36 | MP0003866_abnormal_defecation | 1.75489255 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.66142160 |
| 38 | MP0002419_abnormal_innate_immunity | 1.57454453 |
| 39 | MP0009278_abnormal_bone_marrow | 1.57444694 |
| 40 | MP0005451_abnormal_body_composition | 1.52348629 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.52213592 |
| 42 | MP0008260_abnormal_autophagy | 1.51296588 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.48949343 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.48728077 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.48439919 |
| 46 | MP0006054_spinal_hemorrhage | 1.43711438 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.42578997 |
| 48 | MP0001853_heart_inflammation | 1.37629983 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.37150231 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.31211333 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.31211333 |
| 52 | MP0004510_myositis | 1.26834537 |
| 53 | MP0000858_altered_metastatic_potential | 1.24025669 |
| 54 | MP0004883_abnormal_blood_vessel | 1.19895114 |
| 55 | MP0002009_preneoplasia | 1.17836171 |
| 56 | MP0005023_abnormal_wound_healing | 1.17547166 |
| 57 | MP0003828_pulmonary_edema | 1.17415103 |
| 58 | MP0003091_abnormal_cell_migration | 1.16322205 |
| 59 | MP0003448_altered_tumor_morphology | 1.13089757 |
| 60 | MP0004381_abnormal_hair_follicle | 1.09712713 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.09531280 |
| 62 | MP0003279_aneurysm | 1.05388773 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.04524836 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.04453376 |
| 65 | MP0003045_fibrosis | 1.04111894 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.00677622 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.99138608 |
| 68 | MP0001851_eye_inflammation | 0.98892149 |
| 69 | MP0001348_abnormal_lacrimal_gland | 0.98807943 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.97563786 |
| 71 | MP0002132_abnormal_respiratory_system | 0.97438620 |
| 72 | MP0004130_abnormal_muscle_cell | 0.97328190 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.95446481 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.93951648 |
| 75 | MP0000490_abnormal_crypts_of | 0.93261067 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.88951782 |
| 77 | MP0005164_abnormal_response_to | 0.86480622 |
| 78 | MP0008469_abnormal_protein_level | 0.84203143 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79291446 |
| 80 | MP0000767_abnormal_smooth_muscle | 0.76133874 |
| 81 | MP0008057_abnormal_DNA_replication | 0.74225456 |
| 82 | MP0000733_abnormal_muscle_development | 0.72494751 |
| 83 | MP0003077_abnormal_cell_cycle | 0.71936638 |
| 84 | MP0003690_abnormal_glial_cell | 0.71925961 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.70817100 |
| 86 | MP0003943_abnormal_hepatobiliary_system | 0.70588444 |
| 87 | MP0003787_abnormal_imprinting | 0.69012878 |
| 88 | MP0005310_abnormal_salivary_gland | 0.68160110 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.67483355 |
| 90 | MP0001243_abnormal_dermal_layer | 0.67461245 |
| 91 | MP0005166_decreased_susceptibility_to | 0.67152793 |
| 92 | MP0009764_decreased_sensitivity_to | 0.66632261 |
| 93 | * MP0000249_abnormal_blood_vessel | 0.66411833 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.65984300 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.64676539 |
| 96 | MP0003795_abnormal_bone_structure | 0.64314866 |
| 97 | MP0005621_abnormal_cell_physiology | 0.64311586 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.63965391 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.63147207 |
| 100 | MP0010094_abnormal_chromosome_stability | 0.60387102 |
| 101 | MP0005390_skeleton_phenotype | 0.60082152 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.59967382 |
| 103 | MP0001958_emphysema | 0.59670756 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.59148510 |
| 105 | * MP0002925_abnormal_cardiovascular_devel | 0.58580791 |
| 106 | MP0001191_abnormal_skin_condition | 0.58374073 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.57610711 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.56501377 |
| 109 | MP0009115_abnormal_fat_cell | 0.56378857 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.55440165 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.54661897 |
| 112 | MP0009763_increased_sensitivity_to | 0.54556742 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.54114097 |
| 114 | MP0000609_abnormal_liver_physiology | 0.53743805 |
| 115 | * MP0002128_abnormal_blood_circulation | 0.53655404 |
| 116 | * MP0001784_abnormal_fluid_regulation | 0.53461724 |
| 117 | MP0001663_abnormal_digestive_system | 0.52755191 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.50072750 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.49111675 |
| 120 | MP0001915_intracranial_hemorrhage | 0.48712533 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.48222413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.11490533 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.77635068 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 4.76285087 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.73955590 |
| 5 | Recurrent viral infections (HP:0004429) | 4.71048200 |
| 6 | Abnormality of T cells (HP:0002843) | 4.68640611 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.60683058 |
| 8 | Combined immunodeficiency (HP:0005387) | 4.46557561 |
| 9 | B lymphocytopenia (HP:0010976) | 4.44247936 |
| 10 | Abnormality of B cell number (HP:0010975) | 4.44247936 |
| 11 | Thyroiditis (HP:0100646) | 4.14074547 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.07411331 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.06717757 |
| 14 | Abnormality of the fingertips (HP:0001211) | 4.00050635 |
| 15 | IgM deficiency (HP:0002850) | 3.92164668 |
| 16 | Eosinophilia (HP:0001880) | 3.83037883 |
| 17 | IgG deficiency (HP:0004315) | 3.74879147 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69075168 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.67183557 |
| 20 | Chronic otitis media (HP:0000389) | 3.66473506 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56586344 |
| 22 | Abnormality of eosinophils (HP:0001879) | 3.48611333 |
| 23 | Verrucae (HP:0200043) | 3.37009574 |
| 24 | Papilloma (HP:0012740) | 3.37009574 |
| 25 | Nasal polyposis (HP:0100582) | 3.31185306 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.28452676 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.27523064 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.27523064 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.25884259 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 3.24358118 |
| 31 | Lymphopenia (HP:0001888) | 3.23961412 |
| 32 | Granulocytopenia (HP:0001913) | 3.21014784 |
| 33 | Stomatitis (HP:0010280) | 3.20161078 |
| 34 | Meningitis (HP:0001287) | 3.09849920 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.08950746 |
| 36 | Pustule (HP:0200039) | 3.06926776 |
| 37 | Myositis (HP:0100614) | 3.06824017 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.01851076 |
| 39 | Chronic diarrhea (HP:0002028) | 3.00874050 |
| 40 | Hypoplasia of the thymus (HP:0000778) | 2.97992574 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.96488452 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.86321988 |
| 43 | Leukocytosis (HP:0001974) | 2.86185803 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.77812044 |
| 45 | Papilledema (HP:0001085) | 2.74380557 |
| 46 | IgA deficiency (HP:0002720) | 2.72714311 |
| 47 | Colitis (HP:0002583) | 2.72556623 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.71623265 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.70991683 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.64008702 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.60782866 |
| 52 | Vasculitis (HP:0002633) | 2.59113981 |
| 53 | Gingivitis (HP:0000230) | 2.57354440 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.56137002 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54260228 |
| 56 | Obstructive lung disease (HP:0006536) | 2.54156690 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54156690 |
| 58 | Increased IgM level (HP:0003496) | 2.53591233 |
| 59 | Aortic aneurysm (HP:0004942) | 2.50228856 |
| 60 | Joint swelling (HP:0001386) | 2.48162502 |
| 61 | Bronchitis (HP:0012387) | 2.47936803 |
| 62 | Chronic sinusitis (HP:0011109) | 2.46444494 |
| 63 | Abnormal platelet volume (HP:0011876) | 2.43709377 |
| 64 | Abnormal foot bone ossification (HP:0010675) | 2.41986903 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.41217900 |
| 66 | Hemoptysis (HP:0002105) | 2.39236154 |
| 67 | Encephalitis (HP:0002383) | 2.39059255 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.36867721 |
| 69 | Lymphoma (HP:0002665) | 2.35807608 |
| 70 | Cellulitis (HP:0100658) | 2.34250955 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.30410400 |
| 72 | Optic neuritis (HP:0100653) | 2.30410400 |
| 73 | Emphysema (HP:0002097) | 2.29446301 |
| 74 | Pulmonary infiltrates (HP:0002113) | 2.27033527 |
| 75 | Increased density of long bones (HP:0006392) | 2.25378484 |
| 76 | Osteomyelitis (HP:0002754) | 2.23906637 |
| 77 | Recurrent otitis media (HP:0000403) | 2.21258592 |
| 78 | Bicuspid aortic valve (HP:0001647) | 2.17733024 |
| 79 | Hematochezia (HP:0002573) | 2.15965704 |
| 80 | Increased IgE level (HP:0003212) | 2.15384326 |
| 81 | Arterial thrombosis (HP:0004420) | 2.15060482 |
| 82 | Persistence of primary teeth (HP:0006335) | 2.13653864 |
| 83 | Gingival bleeding (HP:0000225) | 2.13298973 |
| 84 | Orchitis (HP:0100796) | 2.10929615 |
| 85 | Urticaria (HP:0001025) | 2.09623684 |
| 86 | Pulmonary embolism (HP:0002204) | 2.08303019 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.07682503 |
| 88 | Sepsis (HP:0100806) | 2.06962713 |
| 89 | Increased mean platelet volume (HP:0011877) | 2.06749177 |
| 90 | Fatigue (HP:0012378) | 2.00092682 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 1.98364801 |
| 92 | Ureteral stenosis (HP:0000071) | 1.97943969 |
| 93 | Prolonged bleeding time (HP:0003010) | 1.97879125 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.97751521 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 1.96685395 |
| 96 | Hemiplegia (HP:0002301) | 1.95594573 |
| 97 | Hypoproteinemia (HP:0003075) | 1.94063865 |
| 98 | Small epiphyses (HP:0010585) | 1.91303548 |
| 99 | Cerebral aneurysm (HP:0004944) | 1.90906363 |
| 100 | Hypochromic anemia (HP:0001931) | 1.90374675 |
| 101 | Teleangiectasia of the skin (HP:0100585) | 1.89267848 |
| 102 | Glomerulopathy (HP:0100820) | 1.87982613 |
| 103 | Chest pain (HP:0100749) | 1.87497556 |
| 104 | Anorexia (HP:0002039) | 1.87348956 |
| 105 | Abnormality of the pleura (HP:0002103) | 1.86046373 |
| 106 | Recurrent skin infections (HP:0001581) | 1.85461919 |
| 107 | Epistaxis (HP:0000421) | 1.84930915 |
| 108 | Ureteral obstruction (HP:0006000) | 1.84493008 |
| 109 | Hepatitis (HP:0012115) | 1.83691679 |
| 110 | Vertebral arch anomaly (HP:0008438) | 1.81687201 |
| 111 | Viral hepatitis (HP:0006562) | 1.81492114 |
| 112 | Thrombocytosis (HP:0001894) | 1.79932907 |
| 113 | Dislocated radial head (HP:0003083) | 1.78461774 |
| 114 | Glucose intolerance (HP:0000833) | 1.77024448 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 1.76477963 |
| 116 | Skin ulcer (HP:0200042) | 1.75684752 |
| 117 | Restrictive lung disease (HP:0002091) | 1.75614756 |
| 118 | Microcytic anemia (HP:0001935) | 1.73410829 |
| 119 | Limited elbow extension (HP:0001377) | 1.72812797 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.72803104 |
| 121 | Cutis marmorata (HP:0000965) | 1.72524218 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.72485292 |
| 123 | Aortic dissection (HP:0002647) | 1.71957530 |
| 124 | Gastrointestinal infarctions (HP:0005244) | 1.71800397 |
| 125 | Acute hepatic failure (HP:0006554) | 1.71795564 |
| 126 | Gangrene (HP:0100758) | 1.71628856 |
| 127 | Short 4th metacarpal (HP:0010044) | 1.71303194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.45554861 |
| 2 | TXK | 5.08331418 |
| 3 | PRPF4B | 3.85201695 |
| 4 | ITK | 3.25737338 |
| 5 | STK10 | 3.09905627 |
| 6 | RIPK4 | 2.97363219 |
| 7 | FGFR4 | 2.95529229 |
| 8 | JAK3 | 2.75489341 |
| 9 | GRK6 | 2.65183722 |
| 10 | ZAP70 | 2.39819366 |
| 11 | FGFR3 | 2.35572654 |
| 12 | TYK2 | 2.30670930 |
| 13 | MAP3K10 | 2.25908829 |
| 14 | NLK | 2.08440602 |
| 15 | KDR | 2.08330116 |
| 16 | JAK1 | 2.02927151 |
| 17 | IKBKE | 1.90638194 |
| 18 | MAP3K14 | 1.80061426 |
| 19 | TEC | 1.75193127 |
| 20 | TGFBR2 | 1.75121675 |
| 21 | TIE1 | 1.74084604 |
| 22 | CSK | 1.67947026 |
| 23 | LCK | 1.64446965 |
| 24 | PKN2 | 1.64384274 |
| 25 | MARK3 | 1.61052104 |
| 26 | PASK | 1.58858652 |
| 27 | EEF2K | 1.58541971 |
| 28 | TAOK3 | 1.51725650 |
| 29 | MST4 | 1.51299298 |
| 30 | LRRK2 | 1.47981027 |
| 31 | HCK | 1.40895783 |
| 32 | SYK | 1.36689642 |
| 33 | BTK | 1.36102461 |
| 34 | CAMKK2 | 1.30757895 |
| 35 | TTN | 1.29835101 |
| 36 | CDK12 | 1.29562611 |
| 37 | PRKCH | 1.28922460 |
| 38 | PRKCQ | 1.27401813 |
| 39 | CLK1 | 1.17777748 |
| 40 | FGFR2 | 1.16210473 |
| 41 | SMG1 | 1.15082516 |
| 42 | TBK1 | 1.13466745 |
| 43 | MAP3K13 | 1.12753638 |
| 44 | CAMKK1 | 1.08742536 |
| 45 | PIM1 | 1.08663812 |
| 46 | TRIB3 | 1.07393658 |
| 47 | EPHB1 | 1.03221135 |
| 48 | SIK2 | 1.00374975 |
| 49 | PDGFRB | 0.96490739 |
| 50 | FGR | 0.92472945 |
| 51 | MAP3K7 | 0.89703778 |
| 52 | EPHA3 | 0.88852176 |
| 53 | MAP3K1 | 0.88656926 |
| 54 | YES1 | 0.85073897 |
| 55 | CDC42BPA | 0.84781625 |
| 56 | IKBKB | 0.84415122 |
| 57 | MAP2K3 | 0.83065937 |
| 58 | PTK6 | 0.82781894 |
| 59 | JAK2 | 0.81427610 |
| 60 | TGFBR1 | 0.80552370 |
| 61 | RPS6KA4 | 0.79196446 |
| 62 | MELK | 0.76232214 |
| 63 | CSF1R | 0.74076185 |
| 64 | SIK3 | 0.72746101 |
| 65 | STK4 | 0.72708013 |
| 66 | CHUK | 0.72279546 |
| 67 | IRAK1 | 0.70676599 |
| 68 | KSR2 | 0.68736393 |
| 69 | CDK4 | 0.68290905 |
| 70 | KIT | 0.67761596 |
| 71 | LYN | 0.67677102 |
| 72 | BLK | 0.67463749 |
| 73 | STK38 | 0.65188448 |
| 74 | DMPK | 0.65092327 |
| 75 | BMPR2 | 0.64207766 |
| 76 | IRAK4 | 0.62981213 |
| 77 | TAOK1 | 0.61069371 |
| 78 | TYRO3 | 0.60365846 |
| 79 | PRKD2 | 0.59386443 |
| 80 | FES | 0.58867020 |
| 81 | STK24 | 0.58645860 |
| 82 | NUAK1 | 0.58619865 |
| 83 | PIK3CG | 0.58149181 |
| 84 | CDK9 | 0.58001405 |
| 85 | TRPM7 | 0.57533347 |
| 86 | INSR | 0.57107313 |
| 87 | MAP3K3 | 0.56545368 |
| 88 | RIPK1 | 0.54613612 |
| 89 | CDK6 | 0.54387646 |
| 90 | MARK2 | 0.53099300 |
| 91 | SGK3 | 0.51707036 |
| 92 | ERN1 | 0.51245295 |
| 93 | BRD4 | 0.51244985 |
| 94 | SGK2 | 0.49530927 |
| 95 | HIPK2 | 0.48210055 |
| 96 | PDK1 | 0.46966564 |
| 97 | PTK2B | 0.46859354 |
| 98 | FLT3 | 0.46796094 |
| 99 | WNK1 | 0.46514335 |
| 100 | ICK | 0.46514045 |
| 101 | MAP3K11 | 0.43858887 |
| 102 | SIK1 | 0.41856896 |
| 103 | PDPK1 | 0.41216333 |
| 104 | TSSK6 | 0.40876144 |
| 105 | TNK2 | 0.40052580 |
| 106 | TAOK2 | 0.39131187 |
| 107 | ALK | 0.38915515 |
| 108 | NME2 | 0.36567573 |
| 109 | PDGFRA | 0.35996209 |
| 110 | IRAK2 | 0.35797765 |
| 111 | FGFR1 | 0.35208517 |
| 112 | FYN | 0.34484348 |
| 113 | RPS6KL1 | 0.33470433 |
| 114 | RPS6KC1 | 0.33470433 |
| 115 | MAPK11 | 0.31838475 |
| 116 | PRKD1 | 0.30777392 |
| 117 | MAP3K8 | 0.30673305 |
| 118 | NEK2 | 0.30374718 |
| 119 | RPS6KB2 | 0.30054746 |
| 120 | EGFR | 0.28580660 |
| 121 | RET | 0.26348659 |
| 122 | NEK9 | 0.26202570 |
| 123 | IRAK3 | 0.25795899 |
| 124 | TESK2 | 0.25549546 |
| 125 | ABL1 | 0.25115952 |
| 126 | * IGF1R | 0.24318088 |
| 127 | CAMK1D | 0.20926595 |
| 128 | * MAPK3 | 0.20413212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.65782191 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.61538551 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72854989 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.59101598 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51807303 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48654931 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.47479181 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43231082 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.27412425 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22446352 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98660328 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97125835 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.89711488 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77946302 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.77574156 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75210152 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60973978 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51402780 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46241174 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43168092 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41148114 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39685951 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.35129806 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33340281 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31251542 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30916263 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25345076 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.24958139 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21029086 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18806403 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18614733 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.18498859 |
| 33 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.17403923 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13136934 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.12529338 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11778217 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10189195 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.09374067 |
| 39 | Colorectal cancer_Homo sapiens_hsa05210 | 1.09214971 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07502243 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03501254 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.99813085 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 0.98366342 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95186015 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94637605 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93895702 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93612481 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.91476803 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89112932 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86733194 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.85038190 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84900478 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83256793 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82377455 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81684753 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 0.80506487 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79296631 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79001073 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78670859 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.78037793 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71264838 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71046284 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70425328 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69625852 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69608804 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.69297901 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68805047 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67500097 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67383870 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66741180 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66523743 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.63886944 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.61834167 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61571927 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60802099 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.60699829 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60519508 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60342367 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59059647 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.58385548 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57614000 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57333940 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56581958 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56504107 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56276364 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.56164217 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55664560 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55377993 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.53388876 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51188303 |
| 91 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.49774447 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49223767 |
| 93 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.48731325 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47569910 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47432084 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.47290866 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.44954981 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.44802056 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44212171 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43584536 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42121096 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.42079964 |
| 103 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39774865 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.39599738 |
| 105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38131313 |
| 106 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37192509 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36907932 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36173551 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35364630 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34574172 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.33544738 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29698650 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27972448 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27839191 |

